Title:
AMINOHETEROARYL KINASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2022/111621
Kind Code:
A1
Abstract:
Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to cyclin dependent kinases (CDKs). The compounds herein are typically CDK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as cancer.
Inventors:
CHENG DAI (CN)
DING QIANG (CN)
HE ZHIXIANG (CN)
ZHOU XIAOBO (CN)
ZHOU YANG (CN)
YIN XIAOHANG (CN)
XIE ZEQIANG (CN)
DING QIANG (CN)
HE ZHIXIANG (CN)
ZHOU XIAOBO (CN)
ZHOU YANG (CN)
YIN XIAOHANG (CN)
XIE ZEQIANG (CN)
Application Number:
PCT/CN2021/133429
Publication Date:
June 02, 2022
Filing Date:
November 26, 2021
Export Citation:
Assignee:
ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD (CN)
International Classes:
C07D239/48; A61K31/505; A61P35/00
Domestic Patent References:
| WO2002096887A1 | 2002-12-05 | |||
| WO2002096888A1 | 2002-12-05 | |||
| WO2006087230A1 | 2006-08-24 | |||
| WO2010046034A1 | 2010-04-29 |
Attorney, Agent or Firm:
SHANGHAI DIANSHI PARTNERS, P.C. (CN)
Download PDF:
Previous Patent: WIRE HARNESS DEVICE FOR SLIDING DOOR MECHANISM
Next Patent: ADDITIVE DISPENSING DEVICE AND WASHING MACHINE
Next Patent: ADDITIVE DISPENSING DEVICE AND WASHING MACHINE